Introduction
Following topical application, the amide form of vitamin B3, niacinamide (NIA), has been found to improve several dermatological conditions including acne, atopic dermatitis, aging of skin and ultraviolet-induced DNA damage [1, 2] . NIA has also been shown to enhance skin barrier function [3, 4] , reduce pore size, improve skin texture [5] , exert beneficial effects in an autoimmune blistering disorder [1] , and improve the appearance of wrinkles blotchiness and hyper pigmented skin areas [6] . In 2005, the Cosmetic Ingredient Review panel published a report on the safety assessment of NIA noting that the active was used in more than 60 cosmetic formulations [7] . However, there are >500 products currently in use listed as containing NIA in the Environmental Working Group (EWG)
Skin Deep® Cosmetic Database [8] . NIA is largely found in shampoos, skin moisturisers and cleansing formulations [8] . Amounts of NIA ranging from 2-5% are used in products to even out skin colour and tone, enhance skin barrier function, and decrease skin sensitivity to surfactants [4] . Products containing NIA at 3% and 4% are used in body and hand creams and preparations to treat acne respectively [7, 8] .
NIA has a low molecular weight and is a water soluble compound (Table 1 ) and therefore does not possess the ideal physicochemical properties for skin delivery. The aim of the present study was to examine the skin permeation and disposition of NIA from two skin barrier-mimetic formulations compared with a commercial formulation. A secondary aim was to examine how the dose of formulation applied influenced permeation in an artificial membrane and porcine skin. an Agilent G1322A degasser, G1311A quaternary pump, G1329A auto sampler and G1316A thermostat column compartment. Analysis was performed using a Phenomenex Luna Phenyl Hexyl column fitted with a guard column. The length, internal diameter and particle size were 250 mm, 4.6 mm and 5 μm, respectively. The mobile phase consisted of water:methanol (80:20). The pH of the mobile phase was adjusted to 7.0±0.2 using orthophosphoric acid and diethylamine. The mobile phase was degassed using an ultrasonicator (VWR International) prior to use to remove air bubbles.
The flow rate of the mobile phase was 1 mL/min and the column temperature was set at 40°C. The 
NIA content of formulations
The amount of NIA in each formulations was determined by taking known amounts of the formulation in Eppendorf® tubes (n=3). One mL of water:methanol (50:50) solvent mixture was added to the tubes which were shaken for 5 min using a vortex shaker and then placed in an orbital shaker at 32°C for 24 h to extract NIA from the formulations. After 24 h, the tubes were centrifuged at 32°C, 12000 rpm and for 15 min. The supernatant solution was removed, diluted with water:methanol (50:50) and analysed by HPLC.
Permeation and mass balance studies
Permeation studies of NIA in Franz diffusion cells were conducted at three different doses (50, 20 and 5 μL) in silicone membrane and porcine skin as described in detail previously [11, 12] .
Freshly prepared PBS (pH 7.3±0.1) was used as the receptor solution. Once the skin/membrane temperature had equilibrated to 32±1°C, the formulation was applied using an Eppendorf®
Multipette Plus. The donor compartment was occluded using Parafilm® for infinite and pseudo finite doses (20 and 50 μL) and not occluded for the finite dose (5 μL) application. A volume of 200 μL of receptor solution was removed from the receptor compartment at various time intervals up to 24 h, with sample replacement using fresh temperature equilibrated PBS solution. All samples were analysed using HPLC.
At the end of the permeation studies, the skin or membrane surface was washed 5-times for the 20 and 50 μL applications and 3-times for the 5 μL applications with 1 mL of water:methanol 
Results and discussion

Solubility of NIA in water, methanol and PBS
The solubility values of NIA in PBS, methanol and water:methanol (50:50) are shown in Table   2 and confirm PBS as a suitable receptor medium for permeation studies. As the solubility of NIA was 2.6 fold higher in water:methanol (50:50) compared with pure methanol the former was selected for washing and extraction of NIA in mass balance studies. The water methanol solution (50:50) was also used to extract and assay NIA in all formulations. The amount of NIA in Formulations A and B were determined to be 2.92 and 3.17 %w/w, respectively, which were ̴ 97 and 106% of the claimed content; an amount of 3.69 %w/w of NIA was determined for the commercial product (Table 3) . 
Permeation and mass balance results
Permeation studies of NIA from the three formulations were conducted using silicone membrane and porcine skin and with various amounts of formulations, namely infinite, pseudo finite and finite doses. The silicone membrane was selected as a model membrane because of its homogeneity and it also allows insight into the influence of excipients on membrane transport [14, 15] .
For the 50 μL dose, in both membranes, absolute NIA permeation may be ranked as follows Control> Formulation A> Formulation B (Figures 1a and b For the 20 l dose, similar quantities of NIA permeated from the three formulations in porcine skin In porcine skin, for the infinite dose (50 μL) the percentage permeation ranged from 7-14%
and for the finite dose (5 μL) the corresponding value was 17-31%; for the 20 l dose the percentage permeation ranged from 34 -51%. In silicone membrane, the percentage permeation of NIA at 24 h decreased with increasing dose of formulation; the percentage permeation ranges for infinite, pseudo-finite and finite doses were 8.4 -11, 19 -27 and 57 -71%, respectively. Mass balance studies were carried out after each permeation study and the results are shown in Table 4 . For the three doses, retention or deposition of NIA was generally higher in porcine skin compared with silicone membrane. Comparable amounts of NIA were deposited in skin for all formulations for all doses and total skin absorption values are also similar for all formulations (p>0.05). Previously it has been shown that the SPF containing prototype formulation containing lamellar bilayer structures was able to localise UV filters into the outer SC. [16] This demonstrates that the prototype formulation can effectively deliver ingredients to where they are needed for performance in the skin for optimum efficacy. For the finite dose (5 μL), deposition in porcine skin was 5 to 10 fold higher than the silicone membrane (Table 4) which may reflect differences in thickness and/or lipophilicity of the membranes [17] . Total absorption values are also highest for all formulations in silicone membrane for the finite dose studies. Comparatively higher absorption levels (p<0.05) are evident for the 20 μL dose in silicone membrane (20 to 28%) than the 50 μL dose (9 to 11%). For the different dosing conditions, absorption levels in skin may be ranked as follows 20 l = 5 l > 50 l. The skin absorption value of NIA from formulations for the 5 l dose are comparable to results reported by Franz for in vitro finite dose studies of NIA; following application of 4 μg/cm 2 of NIA to human abdominal skin, a total of 28.8% of the active was absorbed [18] .
Absorption values for the 50 l dose conditions are also consistent with previous values for infinite dose permeation studies where 10.9% absorption of NIA was observed for permeation from a 10%
(v/v) aqueous ethanol solution [7] . For the 50 μL dose, there was no significant difference in NIA absorption from the commercial control and the barrier-mimetic formulations (p>0.05) in both membranes. Similar findings are evident for the 20 and 5 μL doses in porcine skin (p>0.05). However, NIA absorption was significantly higher for the commercial control compared with Formulation A (p<0.05) for the 20 l dose in silicone membrane.
For all doses of all formulations applied to silicone membrane, the total recovery values of NIA were within 100±15%. These values lie within the acceptable limit of recovery (85-115%)
established by the Scientific Committee on Consumer Safety for dermal absorption studies [19] . In This will be the focus of a future study.
Conclusions
Despite the higher content of NIA in the control formulation there were no differences in amounts of NIA absorbed between this formulation and the skin barrier-mimetic formulations.
Absolute permeation of NIA in porcine skin was significantly higher for the control formulation 
